| 87 - 87 |
Twist and sheet: Variations on the theme of amyloid
Kirschner DA, Teplow DB, Damas AM |
| 88 - 98 |
Review: History of the amyloid fibril
Sipe JD, Cohen AS |
| 99 - 108 |
Review: Amyloidogenesis-unquestioned answers and unanswered questions
Kisilevsky R |
| 109 - 122 |
Probing the kinetics of beta-amyloid self-association
Murphy RM, Pallitto MR |
| 123 - 129 |
A beta fibrillogenesis: Kinetic parameters for fibril formation from Congo red binding
Inouye H, Kirschner DA |
| 130 - 141 |
The Alzheimer's peptide A beta adopts a collapsed coil structure in water
Zhang S, Iwata K, Lachenmann MJ, Peng JW, Li S, Stimson ER, Lu Y, Felix AM, Maggio JE, Lee JP |
| 142 - 152 |
Solution structures in aqueous SDS micelles of two amyloid beta peptides of A beta(1-28) mutated at the alpha-secretase cleavage site (K16E, K16F)
Poulsen SA, Watson AA, Fairlie DP, Craik DJ |
| 153 - 173 |
Review: Model peptides and the physicochemical approach to beta-amyloids
Lynn DG, Meredith SC |
| 174 - 183 |
Activation barriers to structural transition determine deposition rates of Alzheimer's disease A beta amyloid
Esler WP, Felix AM, Stimson ER, Lachenmann MJ, Ghilardi JR, Lu YA, Vinters HV, Mantyh PW, Lee JP, Maggio JE |
| 184 - 208 |
Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity
Varadarajan S, Yatin S, Aksenova M, Butterfield DA |
| 209 - 216 |
Chelation and intercalation: Complementary properties in a compound for the treatment of Alzheimer's disease
Cherny RA, Barnham KJ, Lynch T, Volitakis I, Li QX, McLean CA, Multhaup G, Beyreuher K, Tanzi RE, Masters CL, Bush AI |
| 217 - 231 |
Studies on the in vitro assembly of A beta 1-40: Implications for the search for A beta fibril formation inhibitors
Goldsbury CS, Wirtz S, Muller SA, Sunderji S, Wicki P, Aebi U, Frey P |
| 232 - 246 |
Self-assembly of beta-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates
Bohrmann B, Adrian M, Dubochet J, Kuner P, Muller F, Huber W, Nordstedt C, Dobeli H |
| 247 - 258 |
Inhibition of beta-amyloid-induced neurotoxicity by imidazopyridoindoles derived from a synthetic combinatorial library
Reixach N, Crooks E, Ostresh JM, Houghten RA, Blondelle SE |
| 259 - 270 |
Review: Modulating factors in amyloid-beta fibril formation
McLaurin J, Yang DS, Yip CM, Fraser PE |
| 271 - 279 |
Abnormal tau-containing filaments in neurodegenerative diseases
Crowther RA, Goedert M |
| 280 - 289 |
Review: Immunoglobulin light chain amyloidosis - The archetype of structural and pathogenic variability
Bellotti V, Mangione P, Merlini G |
| 290 - 299 |
Review: TTR amyloidosis - Structural features leading to protein aggregation and their implications on therapeutic strategies
Damas AM, Saraiva MJ |
| 300 - 309 |
Review: Formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins
El-Agnaf OMA, Irvine GB |
| 310 - 322 |
Prions of yeast as heritable amyloidoses
Wickner RB, Taylor KL, Edskes HK, Maddelein ML, Moriyama H, Roberts BT |
| 323 - 338 |
Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein
Wille H, Prusiner SB, Cohen FE |
| 339 - 351 |
Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants
Morozova-Roche LA, Zurdo J, Spencer A, Noppe W, Receveur V, Archer DB, Joniau M, Dobson CM |
| 352 - 362 |
Amyloid fibril formation from full-length and fragments of amylin
Goldsbury C, Goldie K, Pellaud J, Seelig J, Frey P, Muller SA, Kistler J, Cooper GJS, Aebi U |
| 363 - 370 |
Betabellins 15D and 16D, de novo designed beta-sandwich proteins that have amyloidogenic properties
Lim A, Makhov AM, Bond J, Inouye H, Connors LH, Griffith JD, Erickson BW, Kirschner DA, Costello CE |
